Fred Aslan

President and CEO at Artiva Biotherapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
2 years
Director since
2024

2 years of board service in total across 1 board, counting each seat separately. Longest: Artiva Biotherapeutics Inc., 2 years.

Artiva Biotherapeutics Inc. Director · Chief Executive Officer
2 years · Since 2024

Chief executive roles

Artiva Biotherapeutics Inc. · President and CEO
Since July 2024

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 2, 2026 Artiva Biotherapeutics Inc. Open-market sale −62,178 $4.18 $259,972
Oct 6, 2026 Artiva Biotherapeutics Inc. Open-market sale −23,463 $7.20 $168,880
Oct 5, 2026 Artiva Biotherapeutics Inc. Open-market sale −61,696 $6.84 $421,828
Sep 15, 2026 Artiva Biotherapeutics Inc. Grant or award +110,000 — —
Sep 10, 2026 Artiva Biotherapeutics Inc. Grant or award +45,000 — —
Sep 8, 2026 Artiva Biotherapeutics Inc. Open-market sale −23,429 $10.92 $255,845
Sep 3, 2026 Artiva Biotherapeutics Inc. Open-market sale −61,888 $11.16 $690,670
May 19, 2026 Artiva Biotherapeutics Inc. Open-market sale −27,116 $9.01 $244,315
Feb 15, 2026 Artiva Biotherapeutics Inc. Grant or award +366,850 — —
Feb 15, 2026 Artiva Biotherapeutics Inc. Shares withheld for tax −14,600 $4.00 $58,400
Dec 15, 2025 Artiva Biotherapeutics Inc. Open-market sale −3,187 $6.00 $19,122
Dec 12, 2025 Artiva Biotherapeutics Inc. Grant or award +869,136 — —
Nov 17, 2025 Artiva Biotherapeutics Inc. Open-market sale −6,375 $3.38 $21,548
Nov 15, 2025 Artiva Biotherapeutics Inc. Shares withheld for tax −6,347 $3.25 $20,628
Oct 17, 2025 Artiva Biotherapeutics Inc. Open-market sale −25,500 $6.00 $153,000

Questions about Fred Aslan

What boards is Fred Aslan on?

Fred Aslan sits on the board of Artiva Biotherapeutics Inc.

What company is Fred Aslan the CEO of?

Fred Aslan has been President and CEO of Artiva Biotherapeutics Inc. since July 2024.

How long has Fred Aslan served on boards?

Our records show at least 2 years of board service across 1 board, the earliest from 2024.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.